New Label Warning for FDC of Chlorpheniramine Maleate IP 2mg And Phenylephrine HCI IP 5mg drop/ml
CDSCO has emphasised that all manufacturers of FDC of of Chlorpheniramine Maleate IP 2mg And Phenylephrine HCI IP 5mg drop/ml should mention a warning that ‘FDC should not be used in children below 4 years of age’. This should be included in the label and the package insert/ promotional literature of the drug.
JN.1 Subvariant of COVID-19 Detected in Kerala
The Union Ministry of Health is actively engaged in continuous communication with the State Department of Health in Kerala, closely monitoring various points of entry. As the situation unfolds, health authorities are emphasizing the importance of adherence to safety protocols and encouraging the public to remain vigilant in preventing the spread of COVID-19.
Army Hospital R&R Performs Life-Saving Bone Marrow Transplant for Child with Rare Disorder
The Department of Hematology & Stem Cell Transplantation at the Army Hospital R&R in Delhi Cantt. has successfully conducted a life-saving Bone Marrow Transplant (BMT) for a child diagnosed with a rare primary immunodeficiency disorder. This successful bone marrow transplant not only brings hope to Sushant and his family but also serves as a beacon of hope for countless others grappling with rare primary immunodeficiencies.
Indian Nursing Council (Nurse Practitioner in Emergency and Trauma Care – Postgraduate Residency Program) Regulations, 2022
The Emergency and Trauma Care NP program prepares registered B.Sc. nurses for advanced practice roles as clinical experts, managers, educators and consultants leading to M.Sc. Nursing (Nurse Practitioner in Emergency and Trauma Care).
DGHS Publishes List of Selected Candidates for Medical Records Training
The Directorate General Of Health Services (DGHS) has published a list of candidates that have been selected for Medical Records Training. The notification covers Medical Record Officers (MRO) and Medical Record Technician (MRT) Training Courses.
India’s Family Planning Programme Unaffected by Contraceptive Procurement Concerns
The Union Ministry of Health and Family Welfare (MOHFW) has categorically refuted claims suggesting failure in contraceptive procurement. The Ministry has issued a press release stating that the reports are ill-informed and provide misleading information.
NPPA Takes Measures to Ensure Price Transparency in Pharmaceutical Market
As per existing regulations, every manufacturer producing a scheduled or non-scheduled formulation for sale must prominently display the maximum retail price (MRP) on the label of the container, along with the words “Maximum Retail Price” and “inclusive of all taxes.” Additionally, manufacturers are required to issue a price list to dealers, who must prominently display it on their business premises.
Initiatives Propel Organ Donation Awareness in India
As part of the Azadi ka Amrit Mahotsav, organ donation is being promoted as a “Jan Andolan” or people’s movement through social media channels. The Ministry of Health and Family Welfare (MOHFW) has launched a pledge campaign and a slogan competition on the MyGov platform to encourage public participation. Under the “Angdaan Mahotsav” initiated in July 2023, awareness programs focusing on deceased donor organ donation are being conducted nationwide.
Initiatives to Advance Mental Healthcare Nationwide
Under the District Mental Health Programme (DMHP) essential mental health services are made available at the Community Health Centre (CHC) and Primary Health Centre (PHC) levels. These services encompass outpatient care, assessment, counseling, psycho-social interventions, continuing care and support for individuals with severe mental disorders, drug provisions, outreach services, ambulance services, and a 10-bedded in-patient facility at the district level.
Cough Syrup Manufacturers To Ensure Use of Quality Excipients
The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to all cough syrup manufacturers to ensure the use of quality excipients in the manufacture of cough syrups. This advisory was issued on December 5, 2023.
